About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 291826, 13 pages
http://dx.doi.org/10.1155/2013/291826
Review Article

MicroRNAs: New Insights into Chronic Childhood Diseases

1Department of Pediatrics and Neonatology, Suez Canal University, Ismailia 41522, Egypt
2Department of Pediatrics, Xiangya Hospital of Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China

Received 16 April 2013; Accepted 7 June 2013

Academic Editor: Glen Jickling

Copyright © 2013 Ahmed Omran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Janse, C. S. Uiterwaal, R. J. Gemke, J. L. Kimpen, and G. Sinnema, “A difference in perception of quality of life in chronically ill children was found between parents and pediatricians,” Journal of Clinical Epidemiology, vol. 58, no. 5, pp. 495–502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Omran, D. Elimam, S. Shalaby, J. Peng, and F. Yin, “MicroRNAs: a light into the “Black Box” of neuropediatric diseases,” Neuromolecular Medicine, vol. 14, no. 4, pp. 244–261, 2012. View at Publisher · View at Google Scholar
  3. A. Omran, D. Elimam, K. Webster, L. Shehadeh, and F. Yin, “MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle,” Cardiology in the Young, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  4. Y. Bossé, P. D. Paré, and C. Y. Seow, “Airway wall remodeling in asthma: from the epithelial layer to the adventitia,” Current Allergy and Asthma Reports, vol. 8, no. 4, pp. 357–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Vignola, F. Mirabella, G. Costanzo et al., “Airway remodeling in asthma,” Chest, vol. 123, supplement 3, pp. 417S–422S, 2003. View at Scopus
  6. G. P. Anderson, “Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease,” The Lancet, vol. 372, no. 9643, pp. 1107–1119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. J. Akinbami, J. E. Moorman, P. L. Garbe, and E. J. Sondik, “Status of childhood asthma in the United States, 1980–2007,” Pediatrics, vol. 123, no. 3, pp. S131–S145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. F. Kelley, D. M. Mannino, D. M. Homa, A. Savage-Brown, and F. Holguin, “Asthma phenotypes, risk factors, and measures of severity in a national sample of US children,” Pediatrics, vol. 115, no. 3, pp. 726–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Tan, G. Randall, J. Fan et al., “Allele-specific targeting of microRNAs to HLA-G and risk of asthma,” American Journal of Human Genetics, vol. 81, no. 4, pp. 829–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-W. Su, Y. Yang, M.-L. Lv et al., “Association between single-nucleotide polymorphisms in pre-mirnas and the risk of asthma in a Chinese population,” DNA and Cell Biology, vol. 30, no. 11, pp. 919–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Y. Zhang, M. Zhong, M. Y. Zhang, and K. Lv, “Expression and clinical significance of miR-155 in peripheral blood CD4+; T cells of patients with allergic asthma,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 28, no. 5, pp. 540–543, 2012.
  12. T. X. Lu, A. Munitz, and M. E. Rothenberg, “MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression,” Journal of Immunology, vol. 182, no. 8, pp. 4994–5002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Mattes, A. Collison, M. Plank, S. Phipps, and P. S. Foster, “Antagonism of microRNA-126 suppresses the effector function of T H2 cells and the development of allergic airways disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 44, pp. 18704–18709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. E. Williams, H. Larner-Svensson, M. M. Perry et al., “MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy,” PLoS ONE, vol. 4, no. 6, article e5889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Polikepahad, J. M. Knight, A. O. Naghavi et al., “Proinflammatory role for let-7 microRNAS in experimental asthma,” Journal of Biological Chemistry, vol. 285, no. 39, pp. 30139–30149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Rodriguez, E. Vigorito, S. Clare et al., “Requirement of bic/microRNA-155 for normal immune function,” Science, vol. 316, no. 5824, pp. 608–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Chiba, M. Tanabe, K. Goto, H. Sakai, and M. Misawa, “Down-regulation of miR-133a contributes to up-regulation of RhoA in bronchial smooth muscle cells,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 8, pp. 713–719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kumar, U. Mabalirajan, A. Agrawal, and B. Ghosh, “Proinflammatory role of let-7 miRNAs in experimental asthma?” Journal of Biological Chemistry, vol. 285, no. 48, p. le20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Garbacki, E. di Valentin, V. A. Huynh-Thu et al., “MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets,” PLoS ONE, vol. 6, no. 1, article e16509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. Mayoral, M. E. Pipkin, M. Pachkov, E. van Nimwegen, A. Rao, and S. Monticelli, “MicroRNA-221-222 regulate the cell cycle in mast cells,” Journal of Immunology, vol. 182, no. 1, pp. 433–445, 2009. View at Scopus
  21. R. J. Mayoral, L. Deho, N. Rusca et al., “MiR-221 influences effector functions and actin cytoskeleton in mast cells,” PLoS ONE, vol. 6, no. 10, article e26133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Walsh, “Targeting eosinophils in asthma: current and future state of cytokine-and chemokine-directed monoclonal therapy,” Expert Review of Clinical Immunology, vol. 6, no. 5, pp. 701–704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Y. Kim, R. H. Dekruyff, and D. T. Umetsu, “The many paths to asthma:phenotype shaped by innate and adaptive immunity,” Nature Immunology, vol. 11, no. 7, pp. 577–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. T. Schroeder, A. P. Bieneman, K. L. Chichester, L. Breslin, H. Xiao, and M. C. Liu, “Pulmonary allergic responses augment interleukin-13 secretion by circulating basophils yet suppress interferon-α from plasmacytoid dendritic cells,” Clinical and Experimental Allergy, vol. 40, no. 5, pp. 745–754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Liu, A. Nelson, X. Wang et al., “MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis,” Biochemical and Biophysical Research Communications, vol. 380, no. 1, pp. 177–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kumar, T. Ahmad, A. Sharma et al., “Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 128, no. 5, pp. 1077.e10–1085.e10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Collison, J. Mattes, M. Plank, and P. S. Foster, “Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment,” Journal of Allergy and Clinical Immunology, vol. 128, no. 1, pp. 160–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Radzikinas, L. Aven, Z. Jiang et al., “A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle,” Journal of Neuroscience, vol. 31, no. 43, pp. 15407–15415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Barnes, “Immunology of asthma and chronic obstructive pulmonary disease,” Nature Reviews Immunology, vol. 8, no. 3, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Hammad and B. N. Lambrecht, “Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma,” Nature Reviews Immunology, vol. 8, no. 3, pp. 193–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. T. Holgate, “The epithelium takes centre stage in asthma and atopic dermatitis,” Trends in Immunology, vol. 28, no. 6, pp. 248–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. Schleimer, A. Kato, R. Kern, D. Kuperman, and P. C. Avila, “Epithelium: at the interface of innate and adaptive immune responses,” Journal of Allergy and Clinical Immunology, vol. 120, no. 6, pp. 1279–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zhai, Z. Zhong, C.-Y. A. Chen et al., “Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation,” Molecular and Cellular Biology, vol. 28, no. 24, pp. 7414–7426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Chiba and M. Misawa, “MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma,” Journal of Pharmacological Sciences, vol. 114, no. 3, pp. 264–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Sharma, M. Kumar, T. Ahmad, et al., “Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model,” Journal of Applied Physiology, vol. 113, no. 3, pp. 459–464, 2012. View at Publisher · View at Google Scholar
  36. M. J. Feng, F. Shi, C. Qiu, and W. K. Peng, “MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma,” International Immunopharmacology, vol. 13, no. 3, pp. 347–353, 2012.
  37. D. Schaafsma, R. Gosens, J. Zaagsma, A. J. Halayko, and H. Meurs, “Rho kinase inhibitors: a novel therapeutical intervention in asthma?” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 398–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Kume, “RhoA/Rho-kinase as a therapeutic target in asthma,” Current Medicinal Chemistry, vol. 15, no. 27, pp. 2876–2885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. C. Patterson, G. G. Dahlquist, E. Gyürüs, A. Green, G. Soltész, and EURODIAB Study Group, “Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study,” The Lancet, vol. 373, no. 9680, pp. 2027–2033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants,” The Lancet, vol. 378, no. 9785, pp. 31–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Baroukh, M. A. Ravier, M. K. Loder et al., “MicroRNA-124a regulates foxa2 expression and intracellular signaling in pancreatic β-cell lines,” Journal of Biological Chemistry, vol. 282, no. 27, pp. 19575–19588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. D. M. Keller, E. A. Clark, and R. H. Goodman, “Regulation of microRNA-375 by cAMP in pancreatic β-cells,” Molecular Endocrinology, vol. 26, no. 6, pp. 989–999, 2012. View at Publisher · View at Google Scholar
  43. M. N. Poy, J. Hausser, M. Trajkovski et al., “miR-375 maintains normal pancreatic α- and β-cell mass,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5813–5818, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. L.-L. Sun, B.-G. Jiang, W.-T. Li, J.-J. Zou, Y.-Q. Shi, and Z.-M. Liu, “MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression,” Diabetes Research and Clinical Practice, vol. 91, no. 1, pp. 94–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Zhao, R. Mohan, and X. Tang, “MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (Map4k4) in pancreatic β cells,” Journal of Biological Chemistry, vol. 287, no. 37, pp. 31155–31164, 2012. View at Publisher · View at Google Scholar
  46. C. Bolmeson, J. L. S. Esguerra, A. Salehi, D. Speidel, L. Eliasson, and C. M. Cilio, “Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects,” Biochemical and Biophysical Research Communications, vol. 404, no. 1, pp. 16–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. G. Fred, C. H. Bang-Berthelsen, T. Mandrup-Poulsen, L. G. Grunnet, and N. Welsh, “High glucose suppresses human islet insulin biosynthesis by inducing mir-133a leading to decreased polypyrimidine tract binding protein-expression,” PLoS ONE, vol. 5, no. 5, article e10843, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Plaisance, A. Abderrahmani, V. Perret-Menoud, P. Jacquemin, F. Lemaigre, and R. Regazzi, “MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells,” Journal of Biological Chemistry, vol. 281, no. 37, pp. 26932–26942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Ramachandran, U. Roy, S. Garg, S. Ghosh, S. Pathak, and U. Kolthur-Seetharam, “Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets,” FEBS Journal, vol. 278, no. 7, pp. 1167–1174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. N. Poy, L. Eliasson, J. Krutzfeldt et al., “A pancreatic islet-specific microRNA regulates insulin secretion,” Nature, vol. 432, no. 7014, pp. 226–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Li, X. Xu, Y. Liang et al., “miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression,” International Journal of Clinical and Experimental Pathology, vol. 3, no. 3, pp. 254–264, 2010. View at Scopus
  52. T. J. Pullen, G. da Silva Xavier, G. Kelsey, and G. A. Rutter, “miR-29a and miR-29b contribute to pancreatic β-cell-specific silencing of monocarboxylate transporter 1 (MCT1),” Molecular and Cellular Biology, vol. 31, no. 15, pp. 3182–3194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Wijesekara, L.-H. Zhang, M. H. Kang et al., “miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets,” Diabetes, vol. 61, no. 3, pp. 653–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Roggli, A. Britan, S. Gattesco et al., “Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β-cells,” Diabetes, vol. 59, no. 4, pp. 978–986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Trajkovski, J. Hausser, J. Soutschek et al., “MicroRNAs 103 and 107 regulate insulin sensitivity,” Nature, vol. 474, no. 7353, pp. 649–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Zhu, N. Shyh-Chang, A. V. Segr et al., “The Lin28/let-7 axis regulates glucose metabolism,” Cell, vol. 147, no. 1, pp. 81–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Zhou, H. He, J. X. Mi, C. Li, B. Lee, and Q.-S. Mi, “MicroRNA genes: are they susceptibility candidates for human type 1 diabetes?” Annals of the New York Academy of Sciences, vol. 1150, pp. 72–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Hezova, O. Slaby, P. Faltejskova et al., “microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients,” Cellular Immunology, vol. 260, no. 2, pp. 70–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Roggli, S. Gattesco, D. Caille, et al., “Changes in microrna expression contribute to pancreatic β-cell dysfunction in prediabetic nod mice,” Diabetes, vol. 61, no. 7, pp. 1742–1751, 2012. View at Publisher · View at Google Scholar
  60. G. Sebastiani, F. A. Grieco, I. Spagnuolo, L. Galleri, D. Cataldo, and F. Dotta, “Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 862–866, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. C. H. Bang-Berthelsen, L. Pedersen, T. Fløyel, P. H. Hagedorn, T. Gylvin, and F. Pociot, “Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes,” BMC Genomics, vol. 12, article 97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. F. C. Lynn, P. Skewes-Cox, Y. Kosaka, M. T. McManus, B. D. Harfe, and M. S. German, “MicroRNA expression is required for pancreatic islet cell genesis in the mouse,” Diabetes, vol. 56, no. 12, pp. 2938–2945, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Melkman-Zehavi, R. Oren, S. Kredo-Russo et al., “miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors,” EMBO Journal, vol. 30, no. 5, pp. 835–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Kalis, C. Bolmeson, J. L. S. Esguerra et al., “Beta-cell specific deletion of dicer1 leads to defective insulin secretion and diabetes mellitus,” PLoS ONE, vol. 6, no. 12, article e29166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Gilad, E. Meiri, Y. Yogev et al., “Serum microRNAs are promising novel biomarkers,” PLoS ONE, vol. 3, no. 9, article e3148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. J. D. Johnson, “Proteomic identification of carboxypeptidase E connects lipid-induced β-cell apoptosis and dysfunction in type 2 diabetes,” Cell Cycle, vol. 8, no. 1, pp. 38–42, 2009. View at Scopus
  67. K. S. Gwiazda, T.-L. B. Yang, Y. Lin, and J. D. Johnson, “Effects of palmitate on ER and cytosolic Ca2+ homeostasis in β-cells,” American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 4, pp. E690–E701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. S. D. Jordan, M. Krüger, D. M. Willmes et al., “Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism,” Nature Cell Biology, vol. 13, no. 4, pp. 434–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Balasubramanyam, S. Aravind, K. Gokulakrishnan et al., “Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 197–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. M. Herrera, H. E. Lockstone, J. M. Taylor et al., “MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes,” BMC Medical Genomics, vol. 2, article no. 54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Fujishiro, Y. Gotoh, H. Katagiri et al., “Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes,” Molecular Endocrinology, vol. 17, no. 3, pp. 487–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. Engelman, A. H. Berg, R. Y. Lewis, M. P. Lisanti, and P. E. Scherer, “Tumor necrosis factor α-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes,” Molecular Endocrinology, vol. 14, no. 10, pp. 1557–1569, 2000. View at Scopus
  73. L. Kong, J. Zhu, W. Han et al., “Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A Clinical Study,” Acta Diabetologica, vol. 48, no. 1, pp. 61–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. A. He, L. Zhu, N. Gupta, Y. Chang, and F. Fang, “Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes,” Molecular Endocrinology, vol. 21, no. 11, pp. 2785–2794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Lovis, E. Roggli, D. R. Laybutt et al., “Alterations in MicroRNA expression contribute to fatty Acid-Induced pancreatic β-Cell dysfunction,” Diabetes, vol. 57, no. 10, pp. 2728–2736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. D. S. Karolina, A. Armugam, S. Tavintharan et al., “MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus,” PLoS ONE, vol. 6, no. 8, article e22839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Zampetaki, S. Kiechl, I. Drozdov et al., “Plasma microRNA profiling reveals loss of endothelial miR-126 and other MicroRNAs in type 2 diabetes,” Circulation Research, vol. 107, no. 6, pp. 810–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Kato, J. Zhang, M. Wang et al., “MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3432–3437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Kato, L. Wang, S. Putta et al., “Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells,” Journal of Biological Chemistry, vol. 285, no. 44, pp. 34004–34015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Kato, L. Arce, M. Wang, S. Putta, L. Lanting, and R. Natarajan, “A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells,” Kidney International, vol. 80, no. 4, pp. 358–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Kato, S. Putta, M. Wang et al., “TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN,” Nature Cell Biology, vol. 11, no. 7, pp. 881–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. Q. Wang, Y. Wang, A. W. Minto et al., “MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy,” FASEB Journal, vol. 22, no. 12, pp. 4126–4135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Putta, L. Lanting, G. Sun, G. Lawson, M. Kato, and R. Natarajan, “Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 458–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Kovacs, S. Lumayag, C. Cowan, and S. Xu, “MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats,” Investigative Ophthalmology & Visual Science, vol. 52, no. 7, pp. 4402–4409, 2011. View at Scopus
  85. V. A. O. Silva, A. Polesskaya, T. A. Sousa et al., “Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats,” Molecular Vision, vol. 17, pp. 2228–2240, 2011. View at Scopus
  86. J.-H. Wu, Y. Gao, A.-J. Ren et al., “Altered microRNA expression profiles in retinas with diabetic retinopathy,” Ophthalmic Research, vol. 47, no. 4, pp. 195–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Hermeking, “The miR-34 family in cancer and apoptosis,” Cell Death and Differentiation, vol. 17, no. 2, pp. 193–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Suárez and W. C. Sessa, “MicroRNAs as novel regulators of angiogenesis,” Circulation Research, vol. 104, no. 4, pp. 442–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Urbich, A. Kuehbacher, and S. Dimmeler, “Role of microRNAs in vascular diseases, inflammation, and angiogenesis,” Cardiovascular Research, vol. 79, no. 4, pp. 581–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Xie, N. Xie, Y. Li et al., “Upregulation of TRB2 induced by miR-98 in the early lesions of large artery of type-2 diabetic rat,” Molecular and Cellular Biochemistry, vol. 361, no. 1-2, pp. 305–314, 2012. View at Scopus
  91. A. Caporali, M. Meloni, C. Völlenkle et al., “Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after Limb Ischemia,” Circulation, vol. 123, no. 3, pp. 282–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Meng, J. T. Cao, B. Zhang, Q. Zhou, C. X. Shen, and C. Q. Wang, “Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 1, pp. 64–72, 2012. View at Publisher · View at Google Scholar
  93. B.-Z. Chen, S.-L. Yu, S. Singh et al., “Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells,” Cell Biology International, vol. 35, no. 1, pp. 29–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. Q. Ruan, T. Wang, V. Kameswaran et al., “The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 12030–12035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Liang, S. Kume, and D. Koya, “SIRT1 and insulin resistance,” Nature Reviews Endocrinology, vol. 5, no. 7, pp. 367–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. B. Zhou, C. Li, W. Qi et al., “Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity,” Diabetologia, vol. 55, no. 7, pp. 2032–2043, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Geerts, O. Brouwer, H. Stroink et al., “Onset of intractability and its course over time: The Dutch Study of Epilepsy in Childhood,” Epilepsia, vol. 53, no. 4, pp. 741–751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. M. S. Perry and M. Duchowny, “Surgical management of intractable childhood epilepsy: curative and palliative procedures,” Seminars in Pediatric Neurology, vol. 18, no. 3, pp. 195–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. S. A. Russ, K. Larson, and N. Halfon, “A national profile of childhood epilepsy and seizure disorder,” Pediatrics, vol. 129, no. 2, pp. 256–264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Tao, H. Wu, Q. Lin, et al., “Deletion of astroglial dicer causes non-cell autonomous neuronal dysfunction and degeneration,” Journal of Neuroscience, vol. 31, no. 22, pp. 8306–8319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. R. C. McKiernan, E. M. Jimenez-Mateos, I. Bray, et al., “Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis,” PLoS ONE, vol. 7, no. 5, article e35921, 2012. View at Publisher · View at Google Scholar
  102. K. Hu, C. Zhang, L. Long et al., “Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus,” Neuroscience Letters, vol. 488, no. 3, pp. 252–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. R. M. Risbud, C. Lee, and B. E. Porter, “Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus,” Brain Research, vol. 1424, pp. 53–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Peng, A. Omran, M. U. Ashhab, et al., “Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy,” Journal of Molecular Neuroscience, vol. 50, no. 2, pp. 291–297, 2013. View at Publisher · View at Google Scholar
  105. Y.-J. Song, X.-B. Tian, S. Zhang et al., “Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b,” Brain Research, vol. 1387, pp. 134–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Aronica, K. Fluiter, A. Iyer et al., “Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy,” European Journal of Neuroscience, vol. 31, no. 6, pp. 1100–1107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Omran, J. Peng, C. Zhang, et al., “Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy,” Epilepsia, vol. 53, no. 7, pp. 1215–1224, 2012. View at Publisher · View at Google Scholar
  108. M. U. Ashhab, A. Omran, H. Kong, et al., “Expressions of tumor necrosis factor-alpha and microrna-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy,” Journal of Molecular Neuroscience, 2013. View at Publisher · View at Google Scholar
  109. A. A. Kan, S. van Erp, A. A. H. A. Derijck et al., “Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response,” Cellular and Molecular Life Sciences, vol. 69, no. 18, pp. 3127–3145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Brooks-Kayal, “Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children,” Epilepsia, vol. 52, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Wu, J. Peng, C. Wei et al., “Characterization, using comparative proteomics, of differentially expressed proteins in the hippocampus of the mesial temporal lobe of epileptic rats following treatment with valproate,” Amino Acids, vol. 40, no. 1, pp. 221–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. S. I. Ashraf, A. L. McLoon, S. M. Sclarsic, and S. Kunes, “Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila,” Cell, vol. 124, no. 1, pp. 191–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Rajasethupathy, F. Fiumara, R. Sheridan et al., “Characterization of small RNAs in aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB,” Neuron, vol. 63, no. 6, pp. 803–817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. I. Pichardo-Casas, L. A. Goff, M. R. Swerdel et al., “Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation,” Brain Research, vol. 1436, pp. 20–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. A. S. Nudelman, D. P. Dirocco, T. J. Lambert et al., “Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo,” Hippocampus, vol. 20, no. 4, pp. 492–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. D.-Z. Liu, Y. Tian, B. P. Ander et al., “Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 1, pp. 92–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. E. M. Jimenez-Mateos, I. Bray, A. Sanz-Rodriguez et al., “miRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132,” American Journal of Pathology, vol. 179, no. 5, pp. 2519–2532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. E. M. Jimenez-Mateos, T. Engel, P. Merino-Serrais, et al., “Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects,” Nature Medicine, vol. 18, no. 7, pp. 1087–1094, 2012. View at Publisher · View at Google Scholar
  119. F. Ratjen and G. Döring, “Cystic fibrosis,” The Lancet, vol. 361, no. 9358, pp. 681–689, 2003. View at Publisher · View at Google Scholar · View at Scopus
  120. J. A. Dodge, P. A. Lewis, M. Stanton, and J. Wilsher, “Cystic fibrosis mortality and survival in the UK: 1947–2003,” European Respiratory Journal, vol. 29, no. 3, pp. 522–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. E. Hodson, N. J. Simmonds, W. J. Warwick et al., “An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years,” Journal of Cystic Fibrosis, vol. 7, no. 6, pp. 537–542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. R. L. Gibson, J. L. Burns, and B. W. Ramsey, “Pathophysiology and management of pulmonary infections in cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 8, pp. 918–951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  123. W. Xu, C. Hui, S. S. B. Yu, C. Jing, and H. C. Chan, “MicroRNAs and cystic fibrosis—an epigenetic perspective,” Cell Biology International, vol. 35, no. 5, pp. 463–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. I. K. Oglesby, I. M. Bray, S. H. Chotirmall et al., “miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression,” Journal of Immunology, vol. 184, no. 4, pp. 1702–1709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Bazett, A. Paun, and C. K. Haston, “MicroRNA profiling of cystic fibrosis intestinal disease in mice,” Molecular Genetics and Metabolism, vol. 103, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Bhattacharyya, N. S. Balakathiresan, C. Dalgard et al., “Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8,” Journal of Biological Chemistry, vol. 286, no. 13, pp. 11604–11615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. A. R. Kuhn, K. Schlauch, R. Lao, A. J. Halayko, W. T. Gerthoffer, and C. A. Singer, “MicroRNA expression in human airway smooth muscle cells: Role of miR-25 in regulation of airway smooth muscle phenotype,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 4, pp. 506–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. S. A. Moschos, A. E. Williams, M. M. Perry, M. A. Birrell, M. G. Belvisi, and M. A. Lindsay, “Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids,” BMC Genomics, vol. 8, article 240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Ramachandran, P. H. Karp, P. Jiang, et al., “A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutantcystic fibrosis transmembrane conductance regulator,” Proceedings of the National Academy of Sciences of the United States of America,, vol. 109, no. 33, pp. 13362–13367, 2012. View at Publisher · View at Google Scholar
  130. A. E. Gillen, N. Gosalia, S.-H. Leir, and A. Harris, “MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene,” Biochemical Journal, vol. 438, no. 1, pp. 25–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. F. Megiorni, S. Cialfi, C. Dominici, S. Quattrucci, and A. Pizzuti, “Synergistic post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding,” PLoS ONE, vol. 6, no. 10, article e26601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. J. R. Rao, D. Nelson, J. E. Moore et al., “Non-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis,” British Journal of Biomedical Science, vol. 67, no. 3, pp. 126–132, 2010. View at Scopus